EUVIMEDEUVIMED entdecken
Crossref

What perioperative treatment should be administered to breast cancer patients carrying a BRCA mutation?

Sylwia Dębska-Szmich, Piotr Potemski

Oncology in Clinical Practice · 15.01.2026 · 22

DOI: 10.5603/ocp.112556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Sylwia Dębska-Szmich und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Dębska-Szmich, S., & Potemski, P. (2026). What perioperative treatment should be administered to breast cancer patients carrying a BRCA mutation?. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.112556

Vancouver

Dębska-Szmich S, Potemski P. What perioperative treatment should be administered to breast cancer patients carrying a BRCA mutation?. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.112556

BibTeX
@article{DbskaSzmich2026,
  author = {Dębska-Szmich, Sylwia and Potemski, Piotr},
  title = {What perioperative treatment should be administered to breast cancer patients carrying a BRCA mutation?},
  journal = {Oncology in Clinical Practice},
  year = {2026},
  volume = {22},
  number = {0},
  doi = {10.5603/ocp.112556}
}
Kostenlos starten →